Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 1
1962 1
1963 3
1965 2
1966 2
1967 3
1968 3
1969 1
1970 2
1971 3
1972 3
1973 7
1974 3
1975 4
1976 8
1977 8
1979 8
1980 3
1981 2
1982 4
1983 2
1984 2
1985 6
1986 4
1987 3
1988 7
1989 9
1990 5
1991 5
1992 5
1993 4
1994 2
1996 1
1997 3
1998 7
1999 5
2000 6
2001 9
2002 2
2003 2
2004 5
2005 9
2006 11
2007 13
2008 9
2009 9
2010 11
2011 13
2012 10
2013 14
2014 17
2015 8
2016 7
2017 6
2018 7
2019 8
2020 17
2021 22
2022 20
2023 13
2024 21
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
[Mastodynia. Premenstrual syndrome].
Marinov B, Andreeva A, Pandurska A. Marinov B, et al. Among authors: andreeva a. Akush Ginekol (Sofiia). 2014;53(6):36-40. Akush Ginekol (Sofiia). 2014. PMID: 25993739 Review. Bulgarian.
Syndecans and Pancreatic Ductal Adenocarcinoma.
Betriu N, Bertran-Mas J, Andreeva A, Semino CE. Betriu N, et al. Among authors: andreeva a. Biomolecules. 2021 Feb 25;11(3):349. doi: 10.3390/biom11030349. Biomolecules. 2021. PMID: 33669066 Free PMC article. Review.
Recruitment of trimeric eIF2 by phosphatase non-catalytic subunit PPP1R15B.
Fatalska A, Hodgson G, Freund SMV, Maslen SL, Morgan T, Thorkelsson SR, van Slegtenhorst M, Lorenz S, Andreeva A, Kaat LD, Bertolotti A. Fatalska A, et al. Among authors: andreeva a. Mol Cell. 2024 Feb 1;84(3):506-521.e11. doi: 10.1016/j.molcel.2023.12.011. Epub 2023 Dec 29. Mol Cell. 2024. PMID: 38159565 Free PMC article.
SCOP2 prototype: a new approach to protein structure mining.
Andreeva A, Howorth D, Chothia C, Kulesha E, Murzin AG. Andreeva A, et al. Nucleic Acids Res. 2014 Jan;42(Database issue):D310-4. doi: 10.1093/nar/gkt1242. Epub 2013 Nov 29. Nucleic Acids Res. 2014. PMID: 24293656 Free PMC article.
399 results